Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Unresectable Stage III Non-Small Cell Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT05718297
What this trial is testing

Brigatinib Post Definitive Chemo-radiotherapy in Patients with ALK-fusion Non-small Cell Lung Cancer

Who this might be right for
NSCLC, Stage IIIALK-rearrangement
ETOP IBCSG Partners Foundation
Not applicableUnknownNCT04284215
What this trial is testing

Efficacy and Safety of Albumin Paclitaxel Combined With Cisplatin Chemoradiotherapy for Non-resectable Stage III NSCLC

Who this might be right for
Efficacy and Safety
Guizhou Medical University 68
Testing effectiveness (Phase 2)Ended earlyNCT04958993
What this trial is testing

A Trial of Anlotinib Combined With Concurrent Chemoradiotherapy in Patients With Unresectable Stage III Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Shandong Cancer Hospital and Institute 7
Large-scale testing (Phase 3)Active Not RecruitingNCT05211895
What this trial is testing

A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
AstraZeneca 791
Testing effectiveness (Phase 2)Active Not RecruitingNCT03965689
What this trial is testing

Testing the Combination of MLN4924 (Pevonedistat), Carboplatin, and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Who Have Previously Been Treated With Immunotherapy

Who this might be right for
Metastatic Lung Non-Small Cell Squamous CarcinomaMetastatic Lung Non-Squamous Non-Small Cell CarcinomaStage IIIB Lung Cancer AJCC v8+5 more
National Cancer Institute (NCI)
Large-scale testing (Phase 3)WithdrawnNCT04203511
What this trial is testing

INCMGA00012 in Combination With Chemoradiation in Participants With Stage III Non-Small Cell Lung Cancer (POD1UM-301)

Who this might be right for
Non-small Cell Lung Cancer
Incyte Corporation
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07139041
What this trial is testing

Iparomlimab and Tuvonralimab Plus Chemotherapy for Inducing Conversion to Resectability in Initially Unresectable Stage III NSCLC

Who this might be right for
NSCLC (Non-small-cell Lung Cancer)
Chang Chen 69
Early research (Phase 1)Study completedNCT00738452
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Stage I-IIIB Non-Small Cell Lung Cancer After Completion of Radiation Therapy Alone or Combined Radiation Therapy and Chemotherapy

Who this might be right for
Lung Cancer
City of Hope Medical Center 10
Large-scale testing (Phase 3)Looking for participantsNCT07131319
What this trial is testing

SFRT+Tislelizumab+Platinum Chemotherapy for Unresectable Stage III NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Second Affiliated Hospital of Nanchang University 30
Early research (Phase 1)Study completedNCT00019825
What this trial is testing

Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura

Who this might be right for
Esophageal CancerLung CancerMalignant Mesothelioma+1 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)UnknownNCT05085054
What this trial is testing

Salvage Surgery Following Downstaging of Advanced Non-small Cell Lung Cancer by Targeted Therapy (SDANT)

Who this might be right for
Non Small Cell Lung Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 30
Not applicableStudy completedNCT00900094
What this trial is testing

UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With Cancer

Who this might be right for
Breast CancerColorectal CancerEsophageal Cancer+4 more
University of Michigan Rogel Cancer Center 200
Large-scale testing (Phase 3)Looking for participantsNCT04951635
What this trial is testing

A Phase III Study to Assess the Effects of Almonertinib Following Chemoradiation in Patients With Stage III Unresectable Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd. 150
Testing effectiveness (Phase 2)Looking for participantsNCT06656598
What this trial is testing

Adjuvant Chemotherapy +/- Cemiplimab and Sequential Hypofractionated Radiotherapy in Unfit or Elderly Patients With Stage III Lung Cancer

Who this might be right for
Stage III NSCLC
Intergroupe Francophone de Cancerologie Thoracique 152
Testing effectiveness (Phase 2)Active Not RecruitingNCT06700421
What this trial is testing

Phase II Clinical Study of Adebrelimab Combined with Apatinib in the Treatment of Locally Advanced Non-small Cell Lung Cancer Patients with Radiation Pneumonitis

Who this might be right for
Unresectable Locally Advanced Non-small Cell Lung Cancer
Wei Zhou 32
Early research (Phase 1)Active Not RecruitingNCT04491942
What this trial is testing

Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer

Who this might be right for
Advanced Bile Duct CarcinomaAdvanced Breast CarcinomaAdvanced Cervical Carcinoma+31 more
National Cancer Institute (NCI) 74
Testing effectiveness (Phase 2)Looking for participantsNCT07154290
What this trial is testing

Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung CancerAdvanced Non Small Cell Lung CancerMetastatic Non Small Cell Lung Cancer+1 more
Regeneron Pharmaceuticals 300
Early research (Phase 1)Study completedNCT00032032
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 69
Early research (Phase 1)WithdrawnNCT01731587
What this trial is testing

Anti-cancer MUC1-specific Immunotherapy for Unresectable Stage III Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer (NSCLC) Stage III
Merck KGaA, Darmstadt, Germany
Large-scale testing (Phase 3)Study completedNCT00003387
What this trial is testing

Carboplatin, Paclitaxel, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed During Surgery

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 366
Next Page
27